Browsing by 저자 : Changhoon Yoo
전체 결과 16건 중 1-16 번을 표시중입니다.
- 1 Article A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index Giulia Rovesti ; Francesco Leone ; Giovanni Brandi ; et al 2022
- 2 Article A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIOR Jwa Hoon Kim ; Changhoon Yoo ; Seyoung Seo ; et al 2022
- 3 Article Blockade of GRP78 Translocation to the Cell Surface by HDAC6 Inhibition Suppresses Proliferation of Cholangiocarcinoma Cells Chorong Kim ; Seonmin Lee ; Danbee Kim ; et al 2022
- 4 Article Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancreatic Cancer Sun Hong ; Kyung Won Kim ; Hyo Jung Park ; et al 2022
- 5 Article LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation Eunsil Sung ; Minkyung Ko ; Ju-Young Won ; et al 2022
- 6 Article prediction of margin-negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: diagnostic performance of NCCN criteria for resection vs CT-determined resectability Jong Keon Jang ; Se Jin Choi ; Jae Ho Byun ; et al 2022
- 7 Article Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index Giulia Rovesti ; Francesco Leone ; Giovanni Brandi ; et al 2022
- 8 Article Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis Yeong Hak Bang ; Choong-kun Lee ; Changhoon Yoo ; et al 2022
- 9 Article Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma Sora Kang ; Changhoon Yoo ; So Heun Lee ; et al 2022
- 10 Article Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group Shinkyo Yoon ; Miso Kim ; Yong Sang Hong ; et al 2022
- 11 Article Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment Kang Mo Kim ; Baek-Yeol Ryoo ; Ju Hyun Shim ; et al 2022
- 12 Article Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis Young Seob Shin ; Hee Hyun Park ; Jin-hong Park ; et al 2022
- 13 Article The Casein Kinase 2 Inhibitor CX-4945 Promotes Cholangiocarcinoma Cell Death Through PLK1 DA Sol Lee ; Seonmin Lee ; Chorong Kim ; et al 2022
- 14 Article Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma Samuel Chuah ; Joycelyn Lee ; Yuan Song ; et al 2022
- 15 Article Update on Biliary Cancer Imaging Dong Wook Kim ; So Yeon Kim ; Changhoon Yoo ; et al 2022
-
16
Dissertation
다중형광염색 및 RNA 분석을 이용한 위장관 기질 종양의 포괄적 면역 프로파일링 분석: 티로신키나아제 치료의 종양 면역 미세 환경의 영향
유창훈
2018
1